Response to hepatitis A vaccination in human immunodeficiency virus- infected and - Uninfected homosexual men

Journal of Infectious Diseases

Volumn 176, Issue 4, 1997, Pages 1064-1067

  Neilsen, Graham A ^b   Bodsworth, Nell J ^a   Watts, Norbert ^c  

^a SYDNEY EYE HOSPITAL   (Australia)

^b Indonesia HIV AIDS STD Prev Care P   (Indonesia)

^c CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS A ANTIBODY; HEPATITIS A VACCINE;

ADULT; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; HEADACHE; HEPATITIS A; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; IMMUNOGENICITY; INTRAMUSCULAR DRUG ADMINISTRATION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MYALGIA; NAUSEA; PRIORITY JOURNAL; RASH; SEROCONVERSION; VERTIGO;

EID: 0030861967     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/516512     Document Type: Article

References (15)

1. Schomer K, Douglas JM, Cohn DL, et al. Hepatitis A among homosexual men - United States, Canada, and Australia. MMWR Morb Mortal Wkly Rep 1992;41:161-4.
2. Stewart T. A cluster of cases of hepatitis A in Victoria. Commun Dis Intell 1991;15:246.
3. Ferson MJ, Stokes ML, Bell SM. Hepatitis A: an epidemic in eastern Sydney and the gay community: epidemiological aspects. Venereology 1992;5:154.
4. André FE, D'Hondt E, Delem A, Safary A. Clinical efficacy of the safety and efficacy of an inactivated hepatitis A vaccine: rationale and summary of findings. Vaccine 1992;10(suppl 1):S160-8.
5. Kroon FP, van Dissell JT, de Jong JC, van Furth R. Antibody response to influenza, tetanus and pneumococcal vaccines in HIV-seropositive individuals in relation to the number of CD4 lymphocytes. AIDS 1994; 8:469-76.
6. Opravil M, Matter FL, Blaser J, Lüthy R. Poor antibody response after tetanus and pneumococcal vaccination in immunocompromised, HIV-infected patients. Clin Exp Immunol 1991;84:185-9.
7. Keet IPM, van Doornum G, Safary A, Coutinho RA. Insufficient response to hepatitis B vaccination in HIV-positive homosexual men. AIDS 1992; 6:509-10.
8. Wong EKL, Bodsworth NJ, Slade MA, Mulhall BP, Donovan B. Response to hepatitis B vaccination in a primary care setting: influence of HIV infection, CD4 lymphocyte count, and vaccination schedules. Int J STD AIDS 1996;7:490-4.
9. Stapleton JT. Passive immunisation against hepatitis A. Vaccine 1992; 10(suppl 1):S45-7.
10. Tilzey AT, Palmer SJ, Harrington C, O'Doherty MJ. Hepatitis A vaccine responses in HIV-positive persons with haemophilia. Vaccine 1996;14: 1039-41.
11. Hess G, Clemens R, Bienzle U, Schonfeld C, Schunk B, Bock HL. Immunogenicity and safety of an inactivated hepatitis A vaccine in anti-HIV positive and negative homosexual men. J Med Virol 1995;46:40-2.
12. van Damme P, Matheï C, Thoelen S, Meheus A, Safary A, André FE. Single dose inactivated hepatitis A vaccine: rationale and clinical assessment of the safety and immunogenicity. J Med Virol 1994;44: 435-41.
13. Clemens R, Safary A, Hepbum A, Roche C, Stanburg WJ. Clinical experience with an inactivated hepatitis A vaccine. J Infect Dis 1995; 171(suppl 1):S44-9.
14. Wilde JT, Rymes N, Skidmore S, Swann M. Hepatitis A immunisation in HIV-infected haemophilic patients. Haemophilia 1995;1:196-9.
15. Biggar RJ, Goedert JJ, Hoofnagle JH. Accelerated loss of antibody to hepatitis B surface antigen among immunodeficient homosexual men infected with HIV [letter]. N Engl J Med 1987;316:630-1.